Literature DB >> 12168060

Loss of EphB4 receptor tyrosine kinase protein expression during carcinogenesis of the human breast.

Gilles Berclaz1, Bettina Flütsch, Hans Jörg Altermatt, Valeria Rohrbach, Valentin Djonov, Andrew Ziemiecki, Ekkehard Dreher, Anne-Catherine Andres.   

Abstract

Members of the Eph family of receptor tyrosine kinase have been implicated in cell-cell communication and tissue integrity during embryogenesis. We have previously demonstrated cell type specific and hormone dependent EphB4 expression in the mouse mammary parenchyma suggesting involvement in the homeostasis of this organ. Since disruption of tissue organization is crucial for metastatic dissemination, we have investigated the expression of EphB4 during carcinogenesis of the human breast. Immunohistochemical analysis of 24 normal human breast samples and 124 consecutive breast carcinomas was correlated with tumor characteristics (stage, histology, grade, lymph node involvement) and the expression of ER, PR, Ki-67, p53 and HER2. In normal breast tissue, the EphB4 protein was expressed exclusively in parenchymal cells. Strikingly, a drastic reduction in the number of EphB4 protein expressing cells was observed in almost all invasive carcinomas analyzed, irrespective of the tumor type (p<0.0001). Furthermore, we found a highly significant correlation between EphB4 positivity and low histological grading of the tumor cells (p=0.002) suggesting that in breast cancer, EphB4 expression is not compatible with tumor progression. This raises the possibility that EphB4 could represent a potent tool for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12168060

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  17 in total

1.  Receptor tyrosine kinase EphB4 is a survival factor in breast cancer.

Authors:  S Ram Kumar; Jasbir Singh; Guangbin Xia; Valery Krasnoperov; Loubna Hassanieh; Eric J Ley; Jeffrey Scehnet; Neil G Kumar; Debra Hawes; Michael F Press; Fred A Weaver; Parkash S Gill
Journal:  Am J Pathol       Date:  2006-07       Impact factor: 4.307

Review 2.  Eph-dependent cell-cell adhesion and segregation in development and cancer.

Authors:  Eva Nievergall; Martin Lackmann; Peter W Janes
Journal:  Cell Mol Life Sci       Date:  2011-12-28       Impact factor: 9.261

Review 3.  Clinical relevance of Ephs and ephrins in cancer: lessons from breast, colorectal, and lung cancer profiling.

Authors:  Dana M Brantley-Sieders
Journal:  Semin Cell Dev Biol       Date:  2011-10-21       Impact factor: 7.727

4.  Interplay between EphB4 on tumor cells and vascular ephrin-B2 regulates tumor growth.

Authors:  Nicole K Noren; Mark Lu; Andrew L Freeman; Mitchell Koolpe; Elena B Pasquale
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-05       Impact factor: 11.205

5.  Expression of Ephb2 and Ephb4 in breast carcinoma.

Authors:  Qinghua Wu; Zhenhe Suo; Bjørn Risberg; Mats G Karlsson; Kenneth Villman; Jahn M Nesland
Journal:  Pathol Oncol Res       Date:  2004-03-18       Impact factor: 3.201

Review 6.  Eph and ephrins in epithelial stem cell niches and cancer.

Authors:  Maria Genander
Journal:  Cell Adh Migr       Date:  2012-03-01       Impact factor: 3.405

7.  High-throughput RNAi screening for novel modulators of vimentin expression identifies MTHFD2 as a regulator of breast cancer cell migration and invasion.

Authors:  Laura Lehtinen; Kirsi Ketola; Rami Mäkelä; John-Patrick Mpindi; Miro Viitala; Olli Kallioniemi; Kristiina Iljin
Journal:  Oncotarget       Date:  2013-01

8.  Epigenetic silencing of EphA1 expression in colorectal cancer is correlated with poor survival.

Authors:  N I Herath; J Doecke; M D Spanevello; B A Leggett; A W Boyd
Journal:  Br J Cancer       Date:  2009-03-10       Impact factor: 7.640

Review 9.  The multifaceted roles of Eph/ephrin signaling in breast cancer.

Authors:  Philip Kaenel; Mischa Mosimann; Anne-Catherine Andres
Journal:  Cell Adh Migr       Date:  2012-03-01       Impact factor: 3.405

10.  Low Expression of EphB2, EphB3, and EphB4 in Bladder Cancer: Novel Potential Indicators of Muscular Invasion.

Authors:  Tae Ho Lee; Jin Hyung Heo; Ju Yeon Jeong; Gee Hoon Lee; Dong Soo Park; Tae Hoen Kim
Journal:  Yonsei Med J       Date:  2021-08       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.